But AstraZeneca is saying that it thinks Brilinta can be a multi-billion dollar product.
FORBES: Can Pascal Soriot Turn Around AstraZeneca? It May Come Down To One Drug
That would mean that if everyone eligible for Brilinta got it, 100, 000 lives would be saved.
Brilinta has other advantages (it stops acting quickly) and disadvantages (it must be given twice a day).
Brilinta is actually trailing Effient, a similar medicine from Eli Lilly, in usage.
Astra has confirmed that this means Brilinta will have to surpass Effient.
Astra is starting a big trial to show Brilinta prevents strokes.
AstraZeneca says that this may have been due to an interaction of Brilinta and aspirin and that, according to current cardiovascular guidelines, doctors should be prescribing less aspirin anyway.
应用推荐
模块上移
模块下移
不移动